AbbVie's head of global head of immunology discovery research says the ability to profile patients at the molecular level has the potential to dramatically change treatment for people living with chronic conditions. …
New testing means patients no longer 'defined by their symptoms'
February 26, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Imugene acquires rights to new oncolytic virus technology
July 16, 2019 - - Latest News -
Focus on reality rather than the language
July 16, 2019 - - Latest News -
Patients hope new inquiry will target PHARMAC
July 16, 2019 - - Latest News -
MA considering whether to drop ACCC authorisation
July 16, 2019 - - Latest News -
Is this farewell to 'preserving prescriber choice'?
July 15, 2019 - - Latest News -
Supply chain payment reform triggered debate over an even more complex issue
July 15, 2019 - - Latest News -
The uniQure experience highlights the commercial challenge
July 15, 2019 - - Latest News